The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis for CD69 in stimulated Rhesus macaque (Left Panel) or human (Right Panel) peripheral blood mononuclear cells (PBMC). PBMC from Rhesus or human were stimulated for at least 4-6 hours with 20 ng/mL PMA (Sigma-Aldrich Cat. No. P-8139) and 250 ng/mL calcium ionophore A23187 (Sigma-Aldrich Cat. No. C-9275). Cells were then stained with either a APC-H7 Mouse IgG1, κ isotype control (Cat. No. 560167; dashed line histograms) or with the APC-H7 Mouse Anti-Human CD69 antibody (Cat. No. 560737; solid line histograms). Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis for CD69 in stimulated Rhesus macaque (Left Panel) or human (Right Panel) peripheral blood mononuclear cells (PBMC). PBMC from Rhesus or human were stimulated for at least 4-6 hours with 20 ng/mL PMA (Sigma-Aldrich Cat. No. P-8139) and 250 ng/mL calcium ionophore A23187 (Sigma-Aldrich Cat. No. C-9275). Cells were then stained with either a APC-H7 Mouse IgG1, κ isotype control (Cat. No. 560167; dashed line histograms) or with the APC-H7 Mouse Anti-Human CD69 antibody (Cat. No. 560737; solid line histograms). Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis for CD69 in stimulated Rhesus macaque (Left Panel) or human (Right Panel) peripheral blood mononuclear cells (PBMC). PBMC from Rhesus or human were stimulated for at least 4-6 hours with 20 ng/mL PMA (Sigma-Aldrich Cat. No. P-8139) and 250 ng/mL calcium ionophore A23187 (Sigma-Aldrich Cat. No. C-9275). Cells were then stained with either a APC-H7 Mouse IgG1, κ isotype control (Cat. No. 560167; dashed line histograms) or with the APC-H7 Mouse Anti-Human CD69 antibody (Cat. No. 560737; solid line histograms). Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis for CD69 in stimulated Rhesus macaque (Left Panel) or human (Right Panel) peripheral blood mononuclear cells (PBMC). PBMC from Rhesus or human were stimulated for at least 4-6 hours with 20 ng/mL PMA (Sigma-Aldrich Cat. No. P-8139) and 250 ng/mL calcium ionophore A23187 (Sigma-Aldrich Cat. No. C-9275). Cells were then stained with either a APC-H7 Mouse IgG1, κ isotype control (Cat. No. 560167; dashed line histograms) or with the APC-H7 Mouse Anti-Human CD69 antibody (Cat. No. 560737; solid line histograms). Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis for CD69 in stimulated Rhesus macaque (Left Panel) or human (Right Panel) peripheral blood mononuclear cells (PBMC). PBMC from Rhesus or human were stimulated for at least 4-6 hours with 20 ng/mL PMA (Sigma-Aldrich Cat. No. P-8139) and 250 ng/mL calcium ionophore A23187 (Sigma-Aldrich Cat. No. C-9275). Cells were then stained with either a APC-H7 Mouse IgG1, κ isotype control (Cat. No. 560167; dashed line histograms) or with the APC-H7 Mouse Anti-Human CD69 antibody (Cat. No. 560737; solid line histograms). Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Flow cytometric analysis for CD69 in stimulated Rhesus macaque (Left Panel) or human (Right Panel) peripheral blood mononuclear cells (PBMC). PBMC from Rhesus or human were stimulated for at least 4-6 hours with 20 ng/mL PMA (Sigma-Aldrich Cat. No. P-8139) and 250 ng/mL calcium ionophore A23187 (Sigma-Aldrich Cat. No. C-9275). Cells were then stained with either a APC-H7 Mouse IgG1, κ isotype control (Cat. No. 560167; dashed line histograms) or with the APC-H7 Mouse Anti-Human CD69 antibody (Cat. No. 560737; solid line histograms). Histograms were derived from gated events based on light scattering characteristics for lymphocytes. Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The FN50 monoclonal antibody specifically binds to human CD69. CD69 is also known as activation-induced molecule (AIM), early activation antigen (EA-1), very early activation antigen (VEA), C-type lectin domain family 2 member C (CLEC2C), MLR-3, GP32/28 and Leu-23. CD69 is a transmembrane type II homodimer receptor. CD69 is comprised of disulfide-linked, differentially glycosylated core protein subunits that are approximately 28 and 34 kDa in size. Each subunit contains a C-type lectin domain. CD69 is expressed on activated T, B, and natural killer (NK) lymphocytes, thymocytes, neutrophils, eosinophils and platelets. In normal peripheral blood, a small and variable percentage of lymphocytes typically express detectable membrane CD69 antigen. Upon activation, CD69 antigen expression increases on lymphocytes. Peak CD69 expression generally occurs within 18 hours of activation, preceding the appearance of HLA-DR, IL-2Rα (CD25) and transferrin receptor (CD71). CD69 is highly expressed on the bright CD3+ subset of thymocytes. FN50 monoclonal antibody labels NK cells and most lymphocytes of the follicular mantle and perifollicular/interfollicular zone as well as germinal center T cells of lymph nodes and tonsils. Studies indicate that CD69 serves as a signaling receptor in the activation of a variety of cell types.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.